ARUP's Laboratory Test Directory
| 0060223: Neisseria gonorrhoeae DNA Probe |
| Test Mnemonic: GCDNAP | |
|
Methodology: DNA Probe
Performed: Sun-Sat Reported: 1-2 days |
| Specimen Required: | |
|
Collect: Female endocervical or male urethral swabs. Use Gen-Probe® Pace 2 collection and transport kit. ARUP Supply #: female kit 12575; male kit 12576.
Transport: Swab transported in Gen-Probe® Pace 2 transport tubes at 2-8°C. Pediatric Collection/Transport: This test is not recommended for pediatric patients. Remarks: Gross presence of blood in the specimen may interfere with the test performance. Unacceptable Conditions: Specimens not in Gen-Probe® transport. Conjunctival swabs. Specimens without a swab in transport media. Stability: In Gen-Probe® Pace 2 transport media: Ambient: 1 week; Refrigerated: 1 week; Frozen: 1 week |
|
| Reference Interval: |
|
Positive: Presence of N. gonorrhoeae by nucleic acid probe. Negative: Absence of N. gonorrhoeae by nucleic acid probe. |
| Interpretive Data: | |
|
Nucleic-acid amplification tests (NAAT) are superior to direct DNA probe testing for detection of Neisseria gonorrhoea. For NAAT, refer to Chlamydia trachomatis & Neisseria gonorrhoea by Amplified Detection (APTIMA®) (0060241) or Neisseria gonorrhoea by Amplified Detection (APTIMA®) (0060244). Closely observe instructions for specimen collection and transport using test-specific kits provided by the manufacturer for each specimen type. Culture is recommended for Neisseria gonorrhoea detection in cases of suspected sexual abuse or suspected failure of therapy.
|
| Note: | |
|
Amplification tests are recommended for detection of Neisseria gonorrhoeae from genitourinary sources. Refer to Neisseria gonorrhoeae by Amplified Detection (APTIMA®) (0060244). Direct DNA probe testing is appropriate only for endocervical and urethral specimens. Specimens must be collected and transported in test-specific kits provided by the manufacturer. Culture is recommended for Neisseria gonorrhoeae detection in cases of suspected sexual abuse or suspected failure of therapy. Specimens must be collected and transported in the manufacturer's test specific kits. |
| CPT Code(s): | |
| 87590 |